Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report. 2012

Rabeya Yousuf, and Suria Abdul Aziz, and Nurasyikin Yusof, and Chooi-Fun Leong
Blood Bank Unit, Department of Pathology, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaakob Latif, Cheras, 56000, Kuala Lumpur, Malaysia. cfleong@ppukm.ukm.my.

BACKGROUND Hemolytic disease of the fetus and newborn is most commonly caused by anti-D alloantibody. It is usually seen in Rhesus D (RhD)-negative mothers that have been previously sensitized. We report here a case of hemolytic disease of the fetus and newborn in a newborn baby caused by anti-D and anti-S alloantibodies, born to a mother who was RhD negative, but with no previous serological evidence of RhD alloimmunization. METHODS A one-day-old Chinese baby boy was born to a mother who was group A RhD negative. The baby was jaundiced with hyperbilirubinemia, but with no evidence of infection. His blood group was group A RhD positive, his direct Coombs' test result was positive and red cell elution studies demonstrated the presence of anti-D and anti-S alloantibodies. Investigations performed on the maternal blood during the 22 weeks of gestation showed the presence of anti-S antibodies only. Repeat investigations performed post-natally showed the presence of similar antibodies as in the newborn and an anti-D titer of 1:32 (0.25 IU/mL), which was significant. A diagnosis of hemolytic disease of the fetus and newborn secondary to anti-D and anti-S was made. The baby was treated with phototherapy and close monitoring. He was discharged well after five days of phototherapy. CONCLUSIONS This case illustrates the possibility of an anamnestic response of allo-anti-D from previous sensitization in a RhD-negative mother, or the development of anti-D in mid-trimester. Thus, it highlights the importance of thorough antenatal ABO, RhD blood grouping and antibody screening, and if necessary, antibody identification and regular monitoring of antibody screening and antibody levels for prevention or early detection of hemolytic disease of the fetus and newborn, especially in cases of mothers with clinically significant red cell alloantibody.

UI MeSH Term Description Entries

Related Publications

Rabeya Yousuf, and Suria Abdul Aziz, and Nurasyikin Yusof, and Chooi-Fun Leong
January 2003, Ginekologia polska,
Rabeya Yousuf, and Suria Abdul Aziz, and Nurasyikin Yusof, and Chooi-Fun Leong
November 2020, Oman medical journal,
Rabeya Yousuf, and Suria Abdul Aziz, and Nurasyikin Yusof, and Chooi-Fun Leong
May 2014, Transfusion,
Rabeya Yousuf, and Suria Abdul Aziz, and Nurasyikin Yusof, and Chooi-Fun Leong
January 2013, Asian journal of transfusion science,
Rabeya Yousuf, and Suria Abdul Aziz, and Nurasyikin Yusof, and Chooi-Fun Leong
April 2023, Clinical laboratory,
Rabeya Yousuf, and Suria Abdul Aziz, and Nurasyikin Yusof, and Chooi-Fun Leong
February 2020, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
Rabeya Yousuf, and Suria Abdul Aziz, and Nurasyikin Yusof, and Chooi-Fun Leong
January 1982, Pediatria polska,
Rabeya Yousuf, and Suria Abdul Aziz, and Nurasyikin Yusof, and Chooi-Fun Leong
January 1988, Acta haematologica Polonica,
Rabeya Yousuf, and Suria Abdul Aziz, and Nurasyikin Yusof, and Chooi-Fun Leong
May 1979, Pediatria polska,
Rabeya Yousuf, and Suria Abdul Aziz, and Nurasyikin Yusof, and Chooi-Fun Leong
November 1974, Minerva pediatrica,
Copied contents to your clipboard!